Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03969927 · ClinicalTrials.gov registry record · NA

User-friendliness of a Portable Driving Simulator

A NA study of Stroke and Multiple Sclerosis, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT03969927: Recruiting NA study of Stroke and Multiple Sclerosis, sponsored by University of Kansas Medical Center.

NCT03969927 is a NA study of Stroke and Multiple Sclerosis that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 30 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03969927, a NA study of Stroke and Multiple Sclerosis, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The use of simulators to retrain driving skills of patients with stroke, Parkinson's disease (PD), or multiple sclerosis (MS) is very limited because of cost, space required, and incidence of simulator sickness in high fidelity simulators. The Principal investigator recently developed a low cost low fidelity portable driving simulator (PDS). In this pilot study, the study team will (1) determine the ease of use and occurrence of simulator sickness while operating the low fidelity PDS in a clinic setting and (2) the efficacy of the low fidelity PDS to reproduce the benefits from retraining impaired driving skills of stroke survivors in a high-fidelity simulator. Participants: 30 participants, separated according to neurological condition including stroke, PD, or MS, will be randomly allocated to either the PDS or fixed-base high-fidelity simulator training. Each participant will undergo a pre-training evaluation, five hours of designated training and a post-training assessment, similar to the pre-training evaluation. Data will be analyzed according to study aims. The investigators hypothesize that the simple set up of the PDS will make it easier to use and better decrease the incidence of simulator sickness that typically leads to stopping therapy than the high-fidelity simulator. The investigators hypothesize that improvements in lane maintenance, adherence to speed limits, reaction to traffic lights, and overall reaction time after training using the PDS will not be significantly different from improvements observed after training using the high-fidelity driving simulator.

Primary Outcome

User-Friendliness will be assessed using a User-Friendliness Survey which is a Likert scale. \[1-5 scale with 1 representing the lowest degree of user-friendliness and 5 representing the highest degree of user-friendliness\]

Interventions

  • DEVICE Low-Fidelity PDS
  • DEVICE High Fidelity Fixed-Base Simulator

Study Locations (1)

Kansas

  • Abiodun Akinwuntan - Kansas City

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-08-28
Est. Completion 2025-06-30
Phase NA
University of Kansas Medical Center

408 total trials

What NCT03969927 shows while recruiting

NCT03969927 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Low-Fidelity PDS is the first listed.

NCT03969927 reports a single indexed study location in Kansas.

Frequently Asked Questions

What is clinical trial NCT03969927 about?

NCT03969927 is a clinical study titled "User-friendliness of a Portable Driving Simulator". The use of simulators to retrain driving skills of patients with stroke, Parkinson's disease (PD), or multiple sclerosis (MS) is very limited because of cost, space required, and incidence of simulator sickness in high fidelity simulators. The Principal investigator recently developed a low cost low...

What is the current status of trial NCT03969927?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2019-08-28. Estimated completion is 2025-06-30.

What conditions does trial NCT03969927 study?

This clinical trial studies the following conditions: Stroke, Multiple Sclerosis, Parkinson Disease.

What interventions are being tested in trial NCT03969927?

The interventions under investigation include: Low-Fidelity PDS (DEVICE), High Fidelity Fixed-Base Simulator (DEVICE).

Who is sponsoring clinical trial NCT03969927?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03969927 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03969927's enrollment target sits among peer trials

30 301st of 454 higher than 137 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03969927, the US trial registry maintained by the National Library of Medicine. NCT03969927 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.